Effect of Romosozumab on Trabecular Bone Score Compared to Anti-Resorptive Agents in Postmenopausal Women with Osteoporosis

Mostrar otras versiones (1)

BACKGROUND: Romosozumab has shown significant improvement in bone mineral density (BMD) in previously reported trials. However, BMD reflects only bone strength and does not offer insight into the bone microarchitecture. The trabecular bone score (TBS) is a non-invasive tool used to assess bone micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Chaiho, Kim, Jinyoung, Lim, Yejee, Ha, Jeonghoon, Kang, Moo Il, Baek, Ki-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671022/
https://www.ncbi.nlm.nih.gov/pubmed/34905678
http://dx.doi.org/10.11005/jbm.2021.28.4.317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671022/
https://www.ncbi.nlm.nih.gov/pubmed/34905678
http://dx.doi.org/10.11005/jbm.2021.28.4.317

Ejemplares similares